Journal article
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
Mayo Clinic proceedings, Vol.96(3), pp.601-618
03/01/2021
DOI: 10.1016/j.mayocp.2020.12.006
PMCID: PMC7831394
PMID: 33673913
Abstract
Objective: To report the Mayo Clinic experience with coronavirus disease 2019 (COVID-19) related to patient outcomes.
Methods: We conducted a retrospective chart review of patients with COVID-19 diagnosed between March 1, 2020, and July 31, 2020, at any of the Mayo Clinic sites. We abstracted pertinent comorbid conditions such as age, sex, body mass index, Charlson Comorbidity Index variables, and treatments received. Factors associated with hospitalization and mortality were assessed in univariate and multivariate models.
Results: A total of 7891 patients with confirmed COVID-19 infection with research authorization on file received care across the Mayo Clinic sites during the study period. Of these, 7217 patients were adults 18 years or older who were analyzed further. A total of 897 (11.4%) patients required hospitalization, and 354 (4.9%) received care in the intensive care unit (ICU). All hospitalized patients were reviewed by a COVID-19 Treatment Review Panel, and 77.5% (695 of 897) of inpatients received a COVID-19-directed therapy. Overall mortality was 1.2% (94 of 7891), with 7.1% (64 of 897) mortality in hospitalized patients and 11.3% (40 of 354) in patients requiring ICU care.
Conclusion: Mayo Clinic outcomes of patients with COVID-19 infection in the ICU, hospital, and community compare favorably with those reported nationally. This likely reflects the impact of interprofessional multidisciplinary team evaluation, effective leveraging of clinical trials and available treatments, deployment of remote monitoring tools, and maintenance of adequate operating capacity to not require surge adjustments. These best practices can help guide other health care systems with the continuing response to the COVID-19 pandemic. (C) 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.
Details
- Title: Subtitle
- Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
- Creators
- John Charles O'Horo - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USAJames R. Cerhan - Mayo ClinicElliot J. Cahn - Mayo ClinicPhilippe R. Bauer - Mayo ClinicZelalem Temesgen - Mayo ClinicJon Ebbert - Mayo ClinicAndy Abril - Mayo ClinicOmar M. Abu Saleh - Mayo ClinicMariam Assi - Mayo ClinicElie F. Berbari - Mayo ClinicDennis M. Bierle - Mayo ClinicWendelyn Bosch - Mayo ClinicCharles D. Burger - Mayo Clinic in FloridaEdison J. Cano Cevallos - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USACasey M. Clements - Mayo ClinicEva M. Carmona Porquera - Mayo ClinicNatalia E. Castillo Almeida - Mayo ClinicDouglas W. Challener - Mayo ClinicSupavit Chesdachai - Mayo ClinicIsin Y. Comba - Mayo ClinicCristina G. Corsini Campioli - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USASarah J. Crane - Mayo ClinicAla S. Dababneh - Mayo ClinicMark J. Enzler - Mayo ClinicHind J. Fadel - Mayo ClinicRavindra Ganesh - Mayo ClinicAlice Gallo De Moraes - Mayo ClinicJohn R. Go - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USAJoel E. Gordon - Mayo ClinicPooja R. Gurram - Mayo ClinicPramod K. Guru - Mayo ClinicErika L. Halverson - Mayo ClinicMichael F. Harrison - Mayo Clinic in FloridaHeather A. Heaton - Mayo ClinicRyan Hurt - Mayo ClinicMary J. Kasten - Mayo ClinicAugustine S. Lee - Mayo ClinicEmily R. Levy - Mayo Clinic in FloridaClaudia R. Libertin - Mayo ClinicJorge M. Mallea - Mayo ClinicWilliam F. Marshall - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USAGautam Matcha - Mayo ClinicAnne M. Meehan - Mayo ClinicPablo Moreno Franco - Mayo ClinicWilliam G. Morice - Mayo ClinicJennifer J. O'Brien - Mayo Clinic in FloridaRichard Oeckler - Mayo ClinicSteve Ommen - Mayo ClinicCaitlin P. Oravec - Mayo ClinicRobert Orenstein - Mayo ClinicNatalie J. Ough - Mayo ClinicRaj Palraj - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USABhavesh M. Patel - Mayo ClinicVincent S. Pureza - Mayo ClinicBrian Pickering - Mayo ClinicDavid M. Phelan - Mayo ClinicRaymund R. Razonable - Mayo ClinicStacey Rizza - Mayo ClinicPriya Sampathkumar - Mayo ClinicDevang K. Sanghavi - Mayo ClinicAyan Sen - Mayo ClinicJason L. Siegel - Mayo Clin, Dept Neurol, Rochester, MN 55905 USAKai Singbartl - Mayo ClinicAditya S. Shah - Mayo ClinicF. N. U. Shweta - Mayo ClinicLeigh L. Speicher - Mayo ClinicGina Suh - Mayo ClinicHussam Tabaja - Mayo ClinicAaron Tande - Mayo ClinicHenry H. Ting - Mayo ClinicRussell C. Tontz - Mayo ClinicJames J. Vaillant - Mayo ClinicPaschalis Vergidis - Mayo ClinicMohamed Y. Warsame - Mayo ClinicZachary A. Yetmar - Mayo ClinicCatherine (Cate) D. Zomok - Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USAAmy W. Williams - Mayo ClinicAndrew D. Badley - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Mayo Clinic proceedings, Vol.96(3), pp.601-618
- DOI
- 10.1016/j.mayocp.2020.12.006
- PMID
- 33673913
- PMCID
- PMC7831394
- NLM abbreviation
- Mayo Clin Proc
- ISSN
- 0025-6196
- eISSN
- 1942-5546
- Publisher
- Elsevier
- Number of pages
- 18
- Grant note
- DOI: 10.13039/100004328, name: Genentech, award: AI110173, 109593, AI120698; DOI: 10.13039/100005564, name: Gilead Sciences, award: AI110173, 109593, AI120698; DOI: 10.13039/100000871, name: Mayo Clinic, award: AI110173, 109593, AI120698; DOI: 10.13039/100000060, name: National Institute of Allergy and Infectious Diseases, award: AI110173, 109593, AI120698
- Language
- English
- Date published
- 03/01/2021
- Academic Unit
- Epidemiology
- Record Identifier
- 9984368206802771
Metrics
11 Record Views